PUBLICATIONS · 21859554
Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Lymphoma Myeloma Leuk
- Publication date
- 2011 Dec
- First author
- Zinzani PL
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Zinzani PL
- type
- Author
- name
- Pellegrini C
- type
- Author
- name
- Gandolfi L
- type
- Author
- name
- Stefoni V
- type
- Author
- name
- Quirini F
- type
- Author
- name
- Derenzini E
- type
- Author
- name
- Broccoli A
- type
- Author
- name
- Argnani L
- type
- Author
- name
- Pileri S
- type
- Author
- name
- Baccarani M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Zinzani PL
- type
- Author
- name
- Pellegrini C
- type
- Author
- name
- Gandolfi L
- type
- Author
- name
- Stefoni V
- type
- Author
- name
- Quirini F
- type
- Author
- name
- Derenzini E
- type
- Author
- name
- Broccoli A
- type
- Author
- name
- Argnani L
- type
- Author
- name
- Pileri S
- type
- Author
- name
- Baccarani M
- type
- Author
- bibliography ids
- nci-bib-f548667b3094d25114392f0c
- book metadata
- content sha256
- 9cafdab30031036d29b2e61c17c970137e4347d250629f352f28d087e7100be7
- document type
- citation
- dois
- 10.1016/j.clml.2011.02.001
- electronic publication date
- display
- 2011 May 4
- precision
- day
- year
- 2011
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21859554
- immutable id
- pubmed:21859554@9cafdab30031036d29b2e61c17c970137e4347d250629f352f28d087e7100be7
- journal
- abbreviation
- Clin Lymphoma Myeloma Leuk
- issn electronic
- 2152-2669
- issn print
- Source null
- issue
- 6
- name
- Clinical lymphoma, myeloma & leukemia
- nlm unique id
- 101525386
- pages
- 462-6
- volume
- 11
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21859554
- provenance
- batch id
- 2529ef2eca926738ab13
- provider
- NCBI PubMed ESummary
- record sha256
- 4528e20d6e2322a4618480bcbcf4bff47832d2907e5953547748c10fbde1872d
- response sha256
- 9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
- retrieved at
- 2026-09-09T23:46:42.856296+00:00
- publication date
- display
- 2011 Dec
- precision
- month
- year
- 2011
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle